-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GCQBbpGjYkttPaZ/DLwbmDxxiEcVFGbDsaSMq/GVQMsmWssGr62AtcFc5qZdZNSH DUxoQDFnKqU+hQMVAtIMYA== 0000903423-98-000406.txt : 19981203 0000903423-98-000406.hdr.sgml : 19981203 ACCESSION NUMBER: 0000903423-98-000406 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981202 GROUP MEMBERS: DOLAN MICHAEL J GROUP MEMBERS: KEVIN LAVAN GROUP MEMBERS: STEPHANIE W. ABRAMSON SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: YOUNG & RUBICAM INC CENTRAL INDEX KEY: 0001030048 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING AGENCIES [7311] IRS NUMBER: 131493710 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: SEC FILE NUMBER: 005-54835 FILM NUMBER: 98763008 BUSINESS ADDRESS: STREET 1: 285 MADISON AVE CITY: NEW YORK STATE: NY ZIP: 10017-6486 MAIL ADDRESS: STREET 1: YOUNG & RUBICAM INC STREET 2: 285 MADISON AVE CITY: NEW YORK STATE: NY ZIP: 10017 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DOLAN MICHAEL J CENTRAL INDEX KEY: 0001062126 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: C/O CLEARY GOTLEIB STEEN & HAMILTON STREET 2: 1 LIBERTY PLZ CITY: NEW YORK STATE: NY ZIP: 10006 MAIL ADDRESS: STREET 1: C/O CLEARY GOTLEIB STEEN & HAMILTON STREET 2: 1 LIBERTY PLZ CITY: NEW YORK STATE: NY ZIP: 10006 SC 13D 1 SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Young & Rubicam Inc. - ----------------------------------------------------------------- (Name of Issuer) Common Stock - ----------------------------------------------------------------- (Title of Class of Securities) 987425105 ------------------------------------------- (CUSIP Number) Mark T. McEnroe, c/o Young & Rubicam Inc., 285 Madison Avenue, New York, New York 10017, 212-210-3427 - ----------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 1, 1998 ------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D - ----------------------- ----------------------- CUSIP No. 987425105 Page 2 - ----------------------- ----------------------- - --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Michael J. Dolan - --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - --------------------------------------------------------------------- 3 SEC USE ONLY - --------------------------------------------------------------------- 4 SOURCE OF FUNDS 00 - --------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - --------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - --------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER 0 OF ----------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY OWNED 0 BY ----------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON 419,625 WITH ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 - --------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 419,625 - --------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - --------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) * - --------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN - --------------------------------------------------------------------- SCHEDULE 13D - ----------------------- ----------------------- CUSIP No. 987423105 Page 3 - ----------------------- ----------------------- - --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Stephanie W. Abramson - --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - --------------------------------------------------------------------- 3 SEC USE ONLY - --------------------------------------------------------------------- 4 SOURCE OF FUNDS 00 - --------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - --------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - --------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER 0 OF ----------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY OWNED 0 BY ----------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON 466,978 WITH ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 - --------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 466,978 - --------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - --------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) * - --------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN - --------------------------------------------------------------------- SCHEDULE 13D - ----------------------- ----------------------- CUSIP No. 987425105 Page 4 - ----------------------- ----------------------- - --------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Kevin Lavan - --------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] - --------------------------------------------------------------------- 3 SEC USE ONLY - --------------------------------------------------------------------- 4 SOURCE OF FUNDS 00 - --------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) [ ] - --------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States - --------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER 0 OF ----------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY OWNED 0 BY ----------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON 62,250 WITH ----------------------------------------------------- 10 SHARED DISPOSITIVE POWER 0 - --------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 62,250 - --------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] - --------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) * - --------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON IN - --------------------------------------------------------------------- This Amendment No. 2 (this "Amendment") amends and supplements the Schedule 13D filed on November 13, 1998 (the "Original Schedule 13D"), as amended by Amendment No. 1 filed on November 25, 1998, by Michael J. Dolan, Stephanie W. Abramson and Kevin Lavan with respect to the common stock, $0.01 par value per share ("Common Stock"), of Young & Rubicam Inc., a Delaware corporation (the "Company"). All capitalized terms used in this Amendment and not otherwise defined herein have the meanings ascribed to such terms in the Schedule 13D. Item 4. Purpose of Transaction. Item 4 of the Original Schedule 13D is hereby amended by inserting the following paragraphs immediately prior to the final paragraph thereof. On December 1, 1998, the Y&R Selling Shareholders listed on Schedule 1 hereto, together with certain other stockholders of the Company, closed the sale of Common Stock pursuant to the Underwriting Agreement. Pursuant to the Underwriting Agreement, the Y&R Selling Stockholders sold to the Underwriters, acting through the Representatives, 5,180,647 shares of Common Stock (including 1,047,166 shares of Common Stock issued upon exercise of options held by the Y&R Selling Stockholders) for resale pursuant to the Company's Registration Statement on Form S-1 and the Final Prospectus, at a price of $29.50 per share, less an underwriting discount of $1.18 per share, resulting in net proceeds to the Y&R Selling Stockholders of $28.32 per share of Common Stock. In addition, other stockholders of the Company named in the Underwriting Agreement and the Final Prospectus sold 4,819,353 shares of Common Stock to the Underwriters, acting through the Representatives on the same terms. Item 5. Interest in Securities of the Issuer. Item 5 of the Original Schedule 13D is hereby amended to read in its entirety as follows: (a) At the date hereof, Michael J. Dolan beneficially owns 419,625 shares of Common Stock, constituting less than 1% of the shares outstanding. At the date hereof, Stephanie W. Abramson beneficially owns 466,978 shares of Common Stock, constituting less than 1% of the shares outstanding. At the date hereof, Kevin Lavan beneficially owns 42,250 shares of Common Stock, constituting less than 1% of the shares outstanding. The number of shares of Common Stock beneficially owned by each Reporting Person and the percentage of outstanding shares represented thereby have been computed in accordance with Rule 13d-3 under the Exchange Act. (b) At the date hereof, Michael J. Dolan has the sole power to dispose of 419,625 shares of Common Stock, which includes 104,340 shares of Common Stock which are issuable pursuant to curently exercisable options, held in an individual capacity; Stephanie W. Abramson has the sole power to dispose of 466,978 shares of Common Stock, which includes 26,085 shares of Common Stock which are issuable pursuant to currently exercisable options, held in an individual capacity; and Kevin Lavan has the sole power to dispose of 62,250 outstanding shares of Common Stock held in an individual capacity, which includes 12,000 shares of Common Stock that are issuable pursuant to currently exercisable Options. (c) Except as described herein, the Reporting Persons have effected no transactions in shares of Common Stock during the past 60 days. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: December 2, 1998 By: /s/ Mark T. McEnroe, Attorney-in-Fact, on behalf of Michael J. Dolan -------------------------- Name: Mark T. McEnroe Title: Attorney-in-Fact SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: December 2, 1998 By: /s/ Mark T. McEnroe, Attorney-in-Fact, on behalf of Stephanie W. Abramson -------------------------- Name: Mark T. McEnroe Title: Attorney-in-Fact SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: December 2, 1998 By: /s/ Mark T. McEnroe, Attorney-in-Fact, on behalf of Kevin Lavan -------------------------- Name: Mark T. McEnroe Title: Attorney-in-Fact Schedule 1 Y&R Selling Stockholders as of December 1, 1998 Maximum Number of Shares of Common Stock (including shares of Common Stock issuable upon the exercise of Name of Y&R Selling Stockholder options) - ------------------------------- ---------------------- AIELLO, STEPHEN R. 20,105 ALBINUS, STIG 16,140 ANASTOS, PATRICIA 2,000 BARA, JEAN-MARC 35,588 BAUM, STEPHEN 2,000 BEALLE, KIMBERLY 10,000 BEIJEN, KAREL 3,510 BELL, THEODORE 40,000 BERGERUS-HOBINGER, LEENA 45,570 BJORKMAN, LINCOLN 15,615 BLOCKLIN, JUNE 29,520 BOENDER, RENE 12,078 BOHNE, BONNIE 2,430 BOISROND, ETIENNE 33,750 BOSMA, TIEMEN 55,000 BRANDS, HEINZ GEORG 9,733 BRANIGAN, CRAIG 28,000 BRAUN, JURGEN 71,970 BRITE, JANE 40,000 CHIOCCI, ROGER 14,000 CHYNSKY, IRA 16,000 CLAES, MICHAEL 5,000 COGMAN, DON 61,600 COOMBS, JANET 19,327 CORONNA, DAVID 700 COSTA, JOSE MARIA 15,000 COSTA, MASSIMO 7,406 COZENS, MICHAEL 5,220 CURRAN, BRIAN 15,651 DAVIS, DONALD H. 19,080 De BAKKER, FERDINAND 15,000 DEDEO, JOSEPH E. 201,258 DEUTSCH, LAWRENCE 1,400 DIAMOND, SHELLEY 10,875 DuBOSE, PAMELA 20,000 DUKES, TERRY 6,250 ELLIOTT, DARYL 5,200 EXPOSITO, DAISY 31,709 FAHEY, KEVIN J. 4,500 FARLEY, CHARLES P. 5,000 FARNELL-WATSON, PETER 20,355 FORD, PATRICK 9,000 FORD, RICHARD 18,000 FRANKEL, CLARK J. 26,088 FRANZ, VOLKER 1,000 FREDERICKS, ERIC 39,000 FREDERIKSEN, PETER 9,000 GAZMA, LEON 10,000 GERVASI, ENRICO 9,000 GOMEZESE, OSCAR 2,000 GONZALES, EDUARDO 40,000 GREEN, WILLIAM 10,000 GREENE, DAVID E. 10,000 GUTIERREZ, VICTOR 6,000 HALLEY-WRIGHT, ANDREW 37,125 HANSEN, THOMAS R. 750 HARLEMAN, PETER J. 16,000 HAWRYSH, FRED 17,400 HIMPE, STEFAAN 5,000 HOOD, JAMES W. 35,000 HORN, ROSEANNE 10,350 HOROVITZ, PETER 6,957 HOSP, RICHARD H. 20,000 HOYT, ERIC GARRISON 11,900 HUGHES, ALEX 34,785 HUNT, JEFF 15,279 IBBA, GIGLIOLA 15,000 IGIEL, ROBERT 52,175 JACK, BARBARA 89,370 JEBSEN, PAL MARIUS 28,000 JOHNSTON, WILLIAM B. 6,000 KAPLOVE, JAMES E. 8,000 KENNY, MARY ELLEN 6,522 KISSMANN, EDNA 13,000 KLEIN, ARTHUR R. 30,000 KOH, JACKIE 15,500 KOWALEWSKA, NINA 12,000 KRAKOWSKY, PHILIPPE 6,000 KRAUSS, INGO 150,000 KUGELMAN, STEPHANIE 72,794 KURZ, MITCHELL 356,000 KUSHNER, JAY 11,000 La ROCK, MARTA 10,000 LAING, TIMOTHY 4,135 LEO, DENISE 675 LOES, RENATO ARANTES 39,135 LOMBARDI, MARCO 20,000 MACHTIGER, BENNETT R. 7,000 MACKINNON, DUNCAN 5,000 MALTESE, JOHN F. 16,983 MANSON, ANTHONY S. 16,305 MATTHIES, HELMUT 125,000 MAURICE, MARTIN 15,000 McDUFFEY, ROBERT M. 12,000 McGARRY, JOHN 309,706 McKENNA, STEVEN M. 92,000 McLEAN, GORDON 11,955 McQUEENEY, THOMAS 34,765 MEERSTADT, BERT 8,000 MELZER, WILLIAM C. 73,300 MESKILL-SPENCER, DIANE 22,767 MIDDLETON, CRAIG 31,467 MINEAR, DAVID 12,000 MONTERO, FERNAN 282,000 MOOTZ, FRANS 18,792 MORRIS, JOHN F. 12,432 NELSON, BRUCE S. 6,500 NEWTON, JR., CHARLES G. 7,560 NEWTON, KEITH 26,250 NICHOLSON, LORI 11,379 O'MALLEY, JAMES 13,560 OROHO, STEVE 64,988 O'ROURKE, RAYMOND J. 10,000 OWEN, STEWART 20,000 PARRY, VINCENT P. 10,000 PASTRICK, ROBERT S. 17,220 PEREZ, MANUEL 32,000 PEREZ, RICARDO J. 49,575 PERLMUTTER, DIANE 7,500 PETERS, JOHN 28,710 PHILLIPS, GRAHAM 4,960 POLLAK, TIM 264,000 PORTER, MICHAEL 15,610 POWER, WILLIAM A. 50,000 PRATT, TOM 10,000 PROCTER, BRIAN 6,450 PUPHAL, JOERG 32,000 PUTNAM, JOHN E. 9,173 QUADFLIEG, MATTHIAS 5,475 RANCOURT, SERGE 40,000 RAVIV, SHEILA 15,000 REESER, COURTNEY 12,522 RENTSCHLER, PETER 6,087 RINDLISBACHER, JORG 8,000 RODRIGUEZ, JORGE 1,755 RODWAY, EDWARD 6,450 ROSENTHAL, ILENE 10,000 ROSS, JOHN J. 5,000 ROTHSTEIN, SEITH 33,915 ROUSSET, ALAIN 55,352 SAMET, MICHAEL 38,568 SANDERS, JOHN 20,000 SAVAGE, CHRIS 13,050 SCHETLICK, MATTHEW 7,000 SCHOU, NICO 13,755 SCHUG, ANGELIKA 20,000 SCIELZO, JAMES 23,733 SCRUGGS, JOHN F. 26,085 SEYFERTH, STEVE 10,000 SHARP, KEITH 17,742 SHAW, JESSIE 3,500 SHELDON, ALAN J. 250,000 SINREICH, RICHARD 11,000 SIVE, ROBERT 12,590 SLONE, PETER B. 10,650 SMITH, TIMOTHY H. 6,000 SRERE, LINDA 15,000 STADELER, CHRISTOPH 23,000 STEFANSKI, STANLEY 80,321 STEIGRAD, PETER 1,000 STERN MARRONE, DEBRA 8,000 STOUT, KATHRYN 7,000 THALEN, LARS 14,000 TIMON, CLAY 36,511 TRAUB, WAYNE 5,500 VIJN, PIETER 10,000 WALDMAN, MARVIN 24,100 WALSH, MARY T. 2,000 WEBRE, CHARLES 13,914 WIDMER, BRUNO 65,000 WILLIAMS, DONALD D. 18,000 WILLIAMS, JAMES 22,500 YAGODA, KENNETH 6,000 ZEIGLER, MICHAEL 23,185 Total 5,180,647 EXHIBIT INDEX Exhibit 1 Underwriting Agreement (incorporated by reference to Amendment No. 1 to the Original Schedule 13D filed with the Securities and Exchange Commission on November 25, 1998) Exhibit 2 Joint Filing Agreement (incorporated by reference by reference to the Original Schedule 13D filed with the Securities and Exchange Commission on November 13, 1998) -----END PRIVACY-ENHANCED MESSAGE-----